Info
Significant Ownership

Significant Ownership of Northpond Ventures, LP

Signature - Title: /s/ Patrick Smerkers - By: Northpond Ventures GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Location: Bethesda, MD
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Northpond Ventures, LP.

Notify me when Northpond Ventures, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Northpond Ventures, LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
MREO	Mereo BioPharma Group plc	Ordinary Shares, par value GBP 0.003 per share	6.9%	$136,302,500		54,521,000		Michael P. Rubin	04 Jun 2025
VIGL	Vigil Neuroscience, Inc.	Common Stock, $0.0001 par value per share	0%	$0		0		Northpond Ventures, LP	22 May 2025
CADL	Candel Therapeutics, Inc.	Common Stock, $0.01 par value per share	0%	$0		0		Northpond Ventures, LP	31 Dec 2024

Schedules 13D/G Reported by Northpond Ventures, LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.